
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.760 | 4.760 | 0.000 |
Shares | 58.280 | 58.280 | 0.000 |
Bonds | 37.120 | 37.120 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.374 | 18.111 |
Price to Book | 2.371 | 2.394 |
Price to Sales | 2.703 | 1.929 |
Price to Cash Flow | 12.563 | 10.077 |
Dividend Yield | 2.338 | 2.735 |
5 Years Earnings Growth | 10.598 | 12.194 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 45.120 | 9.914 |
Technology | 24.760 | 22.511 |
Financial Services | 10.260 | 11.560 |
Industrials | 8.360 | 20.139 |
Utilities | 7.770 | 3.915 |
Consumer Cyclical | 3.740 | 11.521 |
Number of long holdings: 17
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
TREASURY COUPON BOND 2025 1 | - | 37.12 | - | - | |
Beijing Kingsoft Office | CNE100003PM2 | 5.44 | 293.18 | -2.37% | |
Mesnac A | CNE000001NX9 | 4.87 | 8.14 | -0.85% | |
Jiangsu Hengrui | CNE0000014W7 | 4.71 | 65.26 | -1.12% | |
Yoke Technology A | CNE100000PG0 | 4.61 | 75.78 | -2.32% | |
Huaneng Power International | CNE000001998 | 4.53 | 7.57 | +1.07% | |
Montage Technology | CNE100003MN7 | 4.38 | 136.36 | -1.90% | |
Jiangzhong Pharm | CNE000000M80 | 4.25 | 21.75 | +0.65% | |
Zhejiang Jiuzhou Pharm | CNE100001W36 | 4.02 | 19.04 | -1.50% | |
Kelun Pharm A | CNE100000PW7 | 3.79 | 35.89 | -0.44% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
KBCGOLDSTATE Consumption Theme | 187.87M | 5.78 | 7.59 | 6.85 | ||
KBC GOLDSTATE Value Growth Stock | 69.77M | 19.99 | 0.50 | -4.00 | ||
Growth Dynamic Asset Allation Mixed | 21.12M | 27.42 | -0.74 | 1.74 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review